315 results
Page 7 of 16
8-K
EX-99.1
77ca bu433947op5j
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
8-K
EX-99.1
fk54gp6n
10 Jun 13
Discovery Labs Responds to FDA Request for Clarification of Recently
12:00am
424B5
sb9un5acea
9 May 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
y4vxnrguipue cvm
15 Apr 13
Other Events
12:00am
8-K/A
EX-10.1
6gctgpef 2azf
15 Mar 13
Financial Statements and Exhibits
12:00am
8-K
EX-99.1
ll2bvtwvf5xmro fw
13 Feb 13
Discovery Labs Receives $30 Million Funding Commitment from Deerfield Management
12:00am
424B5
51fqov3 2591
13 Feb 13
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
fbemt uht6ljh3o1hjfj
8 Jan 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
03ug9u5jfy
4 Jan 13
Discovery Labs Announces Changes to Board of Directors and Appoints a New Chief Executive Officer
12:00am
8-K
EX-99.2
e6ghnqo6jnnm
24 Oct 12
Other Events
12:00am
8-K
EX-99.1
zgioxf
3 May 12
Discovery Labs Reports First Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
us558ddwfpefokik5a3j
29 Mar 12
Discovery Labs Reports Fourth Quarter Financial Results and Highlights Recent Milestones
12:00am
424B5
t59c66
19 Mar 12
Prospectus supplement for primary offering
12:00am